Atlas Trials

A Phase II Clinical Trial of HRS-1893 in the Treatment of Heart Failure With Preserved Ejection Fraction

Clinical trial NCT07269717 · RECRUITING

Trial details

NCT number
NCT07269717
Sponsor
Shandong Suncadia Medicine Co., Ltd.
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Heart Failure With Preserved Ejection Fraction
Start date
2026-03-30
Primary completion
2027-03-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.